Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and …
X Liu, Y Ren, S Qin, Z Yang - BMC Complementary Medicine and …, 2024 - Springer
Abstract Background 6-Methoxydihydrosanguinarine (6-MDS) has shown promising
potential in fighting against a variety of malignancies. Yet, its anti‑lung adenocarcinoma …
potential in fighting against a variety of malignancies. Yet, its anti‑lung adenocarcinoma …